ziprasidone hydrochloride
- Product NDC
- 63629-6916
- 11-digit product format
- 636296916
- Labeler code
- 63629
- Product ID
- 63629-6916_3361a250-9104-2943-e063-6394a90a441f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ziprasidone HCl
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA077561
- Marketing category
- ANDA
- Marketing start
- 2012-05-14
- Substance
- ZIPRASIDONE HYDROCHLORIDE
- Active strength
- 80 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ziprasidone hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ZIPRASIDONE HYDROCHLORIDE | 80 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 216X081ORU |
| Rxcui | 313778 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 63629-6916-1 | 2024-05-16 | C162847 | 48780-1 | 9d75b9d1-0f21-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use ZIPRASIDONE CAPSULES safely and effectively. See full prescribing information for ZIPRASIDONE CAPSULES . ZIPRASIDONE capsules , for oral use Initial U.S. Approval: 2001 |
| 63629-6916-2 | 2024-05-16 | C162847 | 48780-1 | 9d75b9d1-0f21-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use ZIPRASIDONE CAPSULES safely and effectively. See full prescribing information for ZIPRASIDONE CAPSULES . ZIPRASIDONE capsules , for oral use Initial U.S. Approval: 2001 |
| 63629-6916-3 | 2024-05-16 | C162847 | 48780-1 | 9d75b9d1-0f21-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use ZIPRASIDONE CAPSULES safely and effectively. See full prescribing information for ZIPRASIDONE CAPSULES . ZIPRASIDONE capsules , for oral use Initial U.S. Approval: 2001 |
| 63629-6916-4 | 2024-05-16 | C162847 | 48780-1 | 9d75b9d1-0f21-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use ZIPRASIDONE CAPSULES safely and effectively. See full prescribing information for ZIPRASIDONE CAPSULES . ZIPRASIDONE capsules , for oral use Initial U.S. Approval: 2001 |
| 63629-6916-1 | 2024-01-30 | C162847 | 48780-1 | 9d75b9d1-0f21-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use ZIPRASIDONE CAPSULES safely and effectively. See full prescribing information for ZIPRASIDONE CAPSULES . ZIPRASIDONE capsules , for oral use Initial U.S. Approval: 2001 |
| 63629-6916-2 | 2024-01-30 | C162847 | 48780-1 | 9d75b9d1-0f21-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use ZIPRASIDONE CAPSULES safely and effectively. See full prescribing information for ZIPRASIDONE CAPSULES . ZIPRASIDONE capsules , for oral use Initial U.S. Approval: 2001 |
| 63629-6916-3 | 2024-01-30 | C162847 | 48780-1 | 9d75b9d1-0f21-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use ZIPRASIDONE CAPSULES safely and effectively. See full prescribing information for ZIPRASIDONE CAPSULES . ZIPRASIDONE capsules , for oral use Initial U.S. Approval: 2001 |
| 63629-6916-4 | 2024-01-30 | C162847 | 48780-1 | 9d75b9d1-0f21-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use ZIPRASIDONE CAPSULES safely and effectively. See full prescribing information for ZIPRASIDONE CAPSULES . ZIPRASIDONE capsules , for oral use Initial U.S. Approval: 2001 |
| 63629-6916-1 | 2020-10-16 | C162847 | 48780-1 | 9d75b9d1-0f21-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use ZIPRASIDONE CAPSULES safely and effectively. See full prescribing information for ZIPRASIDONE CAPSULES . ZIPRASIDONE capsules , for oral use Initial U.S. Approval: 2001 |
| 63629-6916-2 | 2020-10-16 | C162847 | 48780-1 | 9d75b9d1-0f21-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use ZIPRASIDONE CAPSULES safely and effectively. See full prescribing information for ZIPRASIDONE CAPSULES . ZIPRASIDONE capsules , for oral use Initial U.S. Approval: 2001 |
| 63629-6916-3 | 2020-10-16 | C162847 | 48780-1 | 9d75b9d1-0f21-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use ZIPRASIDONE CAPSULES safely and effectively. See full prescribing information for ZIPRASIDONE CAPSULES . ZIPRASIDONE capsules , for oral use Initial U.S. Approval: 2001 |
| 63629-6916-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0f21-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use ZIPRASIDONE CAPSULES safely and effectively. See full prescribing information for ZIPRASIDONE CAPSULES . ZIPRASIDONE capsules , for oral use Initial U.S. Approval: 2001 |
| 63629-6916-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0f21-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use ZIPRASIDONE CAPSULES safely and effectively. See full prescribing information for ZIPRASIDONE CAPSULES . ZIPRASIDONE capsules , for oral use Initial U.S. Approval: 2001 |
| 63629-6916-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0f21-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use ZIPRASIDONE CAPSULES safely and effectively. See full prescribing information for ZIPRASIDONE CAPSULES . ZIPRASIDONE capsules , for oral use Initial U.S. Approval: 2001 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63629-6916-1 | ziprasidone hydrochloride | 60 in 1 BOTTLE | CAPSULE | 60 | | 14 |
| 63629-6916-2 | ziprasidone hydrochloride | 30 in 1 BOTTLE | CAPSULE | 30 | | 14 |
| 63629-6916-3 | ziprasidone hydrochloride | 28 in 1 BOTTLE | CAPSULE | 28 | | 14 |
| 63629-6916-4 | ziprasidone hydrochloride | 90 in 1 BOTTLE | CAPSULE | 90 | | 14 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63629-6916 | ZIPRASIDONE HYDROCHLORIDE (ZIPRASIDONE HCL) CAPSULE [BRYANT RANCH PREPACK] | 14 | Current NDC, Legacy NDC, 4 package rows | 20250424_947881af-08e6-47eb-87e3-24cc162c12bc.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63629-6916-1 | 63629691601 | 60 CAPSULE in 1 BOTTLE (63629-6916-1) | 60 capsule | 2016-02-08 | 0000-00-00 | No | No | Current |
| 63629-6916-2 | 63629691602 | 30 CAPSULE in 1 BOTTLE (63629-6916-2) | 30 capsule | 2017-04-11 | 0000-00-00 | No | No | Current |
| 63629-6916-3 | 63629691603 | 28 CAPSULE in 1 BOTTLE (63629-6916-3) | 28 capsule | 2024-10-29 | 0000-00-00 | No | No | Current |
| 63629-6916-4 | 63629691604 | 90 CAPSULE in 1 BOTTLE (63629-6916-4) | 90 capsule | 2024-10-29 | 0000-00-00 | No | No | Current |